29 results on '"Tanaka, Kenichi A."'
Search Results
2. The Algorithm Examining the Risk of Massive Transfusion (ALERT) Score Accurately Predicts Massive Transfusion at the Scene of Injury and on Arrival to the Trauma Bay: A Retrospective Analysis.
- Author
-
Chow JH, Richards JE, Galvagno SM, Coleman PJ, Lankford AS, Hendrix C, Dunitz J, Ibrahim I, Ghneim M, Tanaka KA, Scalea TM, Mazzeffi MA, and Hu P
- Subjects
- Adult, Blood Pressure, Female, Hospitalization, Humans, Male, Middle Aged, Predictive Value of Tests, ROC Curve, Retrospective Studies, Risk Assessment, Shock, Hemorrhagic etiology, Trauma Centers, Trauma Severity Indices, Wounds and Injuries therapy, Algorithms, Blood Transfusion, Emergency Medical Services, Shock, Hemorrhagic therapy, Wounds and Injuries complications
- Abstract
Background: Massive transfusion (MT) is required to resuscitate traumatically injured patients with complex derangements. Scoring systems for MT typically require laboratory values and radiological imaging that may delay the prediction of MT., Study Design: The Trauma ALgorithm Examining the Risk of massive Transfusion (Trauma ALERT) study was an observational cohort study. Prehospital and admission ALERT scores were constructed with logistic regression of prehospital and admission vitals, and FAST examination results. Internal validation was performed with bootstrap analysis and cross-validation., Results: The development cohort included 2,592 patients. Seven variables were included in the prehospital ALERT score: systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), respiratory rate (RR), SpO2, motor Glasgow Coma Scale (GCS) score, and penetrating mechanism. Eight variables from 2,307 patients were included in the admission ALERT score: admission SBP, HR, RR, GCS score, temperature, FAST examination result, and prehospital SBP and DBP.The area under the receiving operator characteristic curve for the prehospital and admission models were 0.754 (95% bootstrapped CI 0.735-0.794, P < 0.001) and 0.905 (95% bootstrapped CI 0.867-0.923, P < 0.001), respectively. The prehospital ALERT score had equivalent diagnostic accuracy to the ABC score (P = 0.97), and the admission ALERT score outperformed both the ABC and the prehospital ALERT scores (P < 0.0001)., Conclusion: The prehospital and admission ALERT scores can accurately predict massive transfusion in trauma patients without the use of time-consuming laboratory studies, although prospective studies need to be performed to validate these findings. Early identification of patients who will require MT may allow for timely mobilization of scarce resources and could benefit patients by making blood products available for treating hemorrhagic shock., Competing Interests: The authors report no conflicts of interest., (Copyright © 2021 by the Shock Society.)
- Published
- 2021
- Full Text
- View/download PDF
3. Hematologic evaluation of intraoperative autologous blood collection and allogeneic transfusion in cardiac surgery.
- Author
-
Henderson RA, Judd M, Strauss ER, Gammie JS, Mazzeffi MA, Taylor BS, and Tanaka KA
- Subjects
- Aged, Blood Coagulation physiology, Blood Coagulation Tests, Erythrocyte Transfusion, Female, Hematocrit, Humans, Male, Middle Aged, Observational Studies as Topic, Prospective Studies, Thrombelastography, Blood Transfusion methods, Cardiac Surgical Procedures methods, Cardiopulmonary Bypass methods, Intraoperative Care methods, Operative Blood Salvage
- Abstract
Background: Acute normovolemic hemodilution is recommended as a technique to reduce allogeneic red blood cell (RBC) transfusions in cardiac surgery, but its efficacy to reduce non-RBC transfusion has not been consistently demonstrated. We hypothesized that intraoperative large-volume autologous whole blood (AWB) collection and reinfusion improves viscoelastic coagulation parameters., Study Design and Methods: Prospective observational study of cardiac surgery patients at the University of Maryland Medical Center between December 2017 and August 2019. Rotational thromboelastometry parameters were compared between AWB and control groups (n = 25 in each group) at three time points: T1, baseline; T2, on cardiopulmonary bypass (CPB) after the cross-clamp removal; and T3, 30-60 minutes after protamine administration. The study's primary outcomes were whole blood viscoelastic coagulation parameters that included EXTEM clotting time (CT), FIBTEM amplitude at 10 minutes, and EXTEM amplitude at 10 minutes (EXTEM-A
10 ). Chest tube drainage and allogeneic transfusion were secondary outcomes., Results: Reinfusion of AWB after CPB resulted in a significantly shorter EXTEM CT; mean difference, -11.4 seconds (-21.4 to -1.4; P = .03). It also resulted in a greater percentage increase in EXTEM A10 from T2 to T3; mean difference, 7.8% (95% CI, 1.1%-14.5%; P = .02). Statistical significance was not found in 24-hour chest tube drainage., Conclusion: Large-volume AWB collection and reinfusion are feasible in selected cardiac surgical patients, and may be associated with prohemostatic effects according to thromboelastometry, warranting further investigation with a prospective randomized study., (© 2021 AABB.)- Published
- 2021
- Full Text
- View/download PDF
4. Impact of Preoperative Platelet Count on Bleeding Risk and Allogeneic Transfusion in Multilevel Spine Surgery.
- Author
-
Chow JH, Chancer Z, Mazzeffi MA, McNeil JS, Sokolow MJ, Gaines TM, Reif MM, Trinh AT, Wellington IJ, Camacho JE, Bruckner JJ, Tanaka KA, and Ludwig S
- Subjects
- Adult, Aged, Cohort Studies, Female, Hematopoietic Stem Cell Transplantation, Humans, Male, Middle Aged, Platelet Transfusion, Postoperative Complications, Retrospective Studies, Thrombocytopenia complications, Blood Transfusion, Hemorrhage etiology, Neurosurgical Procedures adverse effects, Platelet Count, Spine surgery
- Abstract
Study Design: This was an observational cohort study of patients receiving multilevel thoracic and lumbar spine surgery., Objective: The aim of this study was to identify which patients are at high risk for allogeneic transfusion which may allow for better preoperative planning and employment of specific blood management strategies., Summary of Background Data: Multilevel posterior spine surgery is associated with a significant risk for major blood loss, and allogeneic blood transfusion is common in spine surgery., Methods: A univariate logistic regression model was used to identify variables that were significantly associated with intraoperative allogeneic transfusion. A multivariate forward stepwise logistic regression model was then used to measure the adjusted association of these variables with intraoperative transfusion., Results: Multilevel thoracic and lumbar spine surgery was performed in 921 patients. When stratifying patients by preoperative platelet count, patients with pre-operative thrombocytopenia and severe thrombocytopenia had a significantly higher rate of transfusion than those who were not thrombocytopenic. Furthermore, those with severe thrombocytopenia had a higher rate of red blood cells, fresh frozen plasma, and platelet transfusion than those with higher platelet counts. Multivariate logistic regression found that preoperative platelet count was the most significant contributor to transfusion, with a platelet count ≤100 having an adjusted odds ratio (OR) of transfusion of 4.88 (95% confidence interval [CI] 1.58-15.02, P = 0.006). Similarly, a platelet count between 101and 150 also doubled the risk of transfusion with an adjusted OR of 2.02 (95% CI 1.01-4.04, P = 0.047). The American Society of Anesthesiologists classification score increased the OR of transfusion by 2.5 times (OR = 2.52, 95% CI 1.54-4.13), whereas preoperative prothrombin time and age minimally increased the risk., Conclusion: Preoperative thrombocytopenia significantly contributes to intraoperative transfusion in multilevel thoracic lumbar spine surgery. Identifying factors that may increase the risk for transfusion could be of great benefit in better preoperative counseling of patients and in reducing overall cost and postoperative complications by implementing strategies and techniques to reduce blood loss and blood transfusions., Level of Evidence: 2.
- Published
- 2021
- Full Text
- View/download PDF
5. Impact of intraoperative high-volume autologous blood collection on allogeneic transfusion during and after cardiac surgery: a propensity score matched analysis.
- Author
-
Henderson RA, Mazzeffi MA, Strauss ER, Williams B, Wipfli C, Dawood M, Taylor BS, and Tanaka KA
- Subjects
- Adult, Aged, Blood Transfusion methods, Blood Transfusion mortality, Case-Control Studies, Female, Hospital Mortality, Humans, Intraoperative Care statistics & numerical data, Male, Maryland epidemiology, Middle Aged, Morbidity, Postoperative Care methods, Postoperative Complications blood, Postoperative Complications epidemiology, Postoperative Complications etiology, Postoperative Hemorrhage epidemiology, Postoperative Hemorrhage etiology, Postoperative Hemorrhage therapy, Propensity Score, Retrospective Studies, Transfusion Reaction, Transplantation, Homologous adverse effects, Transplantation, Homologous mortality, Transplantation, Homologous statistics & numerical data, Blood Transfusion statistics & numerical data, Blood Transfusion, Autologous methods, Blood Transfusion, Autologous mortality, Blood Transfusion, Autologous statistics & numerical data, Cardiac Surgical Procedures adverse effects, Cardiac Surgical Procedures methods, Cardiac Surgical Procedures mortality, Cardiac Surgical Procedures statistics & numerical data, Intraoperative Care methods, Operative Blood Salvage methods, Operative Blood Salvage statistics & numerical data
- Abstract
Background: Perioperative use of allogeneic blood products is associated with higher morbidity, mortality, and hospital costs after cardiac surgery. Blood conservation techniques such as acute normovolemic hemodilution (ANH) report variable success. We hypothesized that large-volume ANH with limited hemodilution would reduce allogeneic blood transfusion compared to the standard practice., Study Design and Methods: Retrospective observational study of cardiac surgery patients at the University of Maryland Medical Center between January 2014 and September 2017. Using the institutional Society of Thoracic Surgeons database 91 autologous and 981 control patients who underwent coronary artery bypass grafting, aortic valve replacement, or both were identified. After propensity matching of 13 preoperative characteristics, 84 autologous and 84 control patients were evaluated. Our primary endpoint was avoidance of blood transfusion during index hospitalization, and secondary endpoints were postoperative bleeding and major adverse outcomes., Results: The median harvest volumes in the ANH and control groups were 1100 mL and 400 mL, respectively. Of the ANH group, 25% received any transfusion versus 45.2% of the control group after propensity score matching (p < 0.006). When controlling for preoperative platelet count, the transfusion rate ratios for ANH were 0.58 (95% confidence interval, 0.39-0.88) for RBCs and 0.63 (0.44-0.89) for non-RBC components, which were both found to be statistically significant. There was no difference found in major adverse events., Conclusion: These results suggest that large-volume ANH is beneficial in reducing both RBC and non-RBC component usage in cardiac surgery. A further prospective validation is warranted., (© 2019 AABB.)
- Published
- 2019
- Full Text
- View/download PDF
6. Transfusion Makeovers by Thromboelastometry-Does It Work for Everyone?
- Author
-
Bolliger D and Tanaka KA
- Subjects
- Hemostasis, Humans, Prospective Studies, Registries, Blood Transfusion, Thrombelastography
- Published
- 2019
- Full Text
- View/download PDF
7. Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery.
- Author
-
Bolliger D and Tanaka KA
- Subjects
- Algorithms, Blood Coagulation Factors metabolism, Blood Platelets, Clinical Trials as Topic, Elasticity, Erythrocytes cytology, Hematocrit, Hemodilution, Hemoglobins analysis, Hemostasis, Humans, Odds Ratio, Plasma metabolism, Platelet Count, Platelet Transfusion methods, Prospective Studies, Randomized Controlled Trials as Topic, Retrospective Studies, Transfusion Reaction, Treatment Outcome, Viscosity, Blood Transfusion methods, Cardiac Surgical Procedures methods, Thrombelastography methods
- Abstract
The value of thrombelastography (TEG) and thromboelastometry (ROTEM) to improve perioperative hemostasis is under debate. We aimed to assess the effects of TEG- or ROTEM-guided therapy in patients undergoing cardiac surgery on the use of allogeneic blood products. We analyzed 12 trials including 6835 patients, 749 of them included in 7 randomized controlled trials (RCTs). We collected data on the amount of transfused allogeneic blood products and on the proportion of patients who received allogeneic blood products or coagulation factor concentrates. Including all trials, the odds ratios (ORs) for transfusion of red blood cell (RBC) concentrates, fresh-frozen plasma (FFP), and platelets were 0.62 (95% confidence interval [CI], 0.56-0.69; P<.001), 0.28 (95% CI, 0.24-0.33; P<.001), and 0.55 (95% CI, 0.49-0.62; P<.001), respectively. However, more than 50% of the patients in this analysis were derived from one retrospective study. Including RCTs only, the ORs for transfusion of RBC, FFP, and platelets were 0.54 (95% CI, 0.38-0.77; P<.001), 0.36 (95% CI, 0.25-0.53; P<.001), and 0.57 (95% CI, 0.39-0.81; P=.002), respectively. The use of coagulation factor concentrates was reported in 6 studies, 2 of them were RCTs. The ORs for the infusion of fibrinogen and prothrombin complex concentrate were 1.56 (95% CI, 1.29-1.87; P<.001) and 1.74 (95% CI, 1.40-2.18; P<.001), respectively. However, frequencies and amounts were similar in the intervention and control group in the 2 RCTs. It is presumed that TEG- or ROTEM-guided hemostatic management reduces the proportion of patients undergoing cardiac surgery transfused with RBC, FFP, and platelets. This presumption is strongly supported by similar ORs found in the analysis including RCTs only. Patient blood management based on the transfusion triggers by TEG or ROTEM appears to be more restrictive than the one based on conventional laboratory testing. However, evidence for improved clinical outcome is limited at this time., (© 2013.)
- Published
- 2013
- Full Text
- View/download PDF
8. Emerging haemostatic agents and patient blood management.
- Author
-
Tanaka KA and Kor DJ
- Subjects
- Animals, Blood Transfusion methods, Disease Management, Hemorrhage blood, Humans, Isotonic Solutions therapeutic use, Plasma Substitutes therapeutic use, Platelet Transfusion methods, Platelet Transfusion trends, Blood Transfusion trends, Hemorrhage therapy, Hemostatics therapeutic use
- Abstract
The transfusion of allogeneic blood products has been considered as a life-saving procedure for patients suffering from major traumatic injury and those who are undergoing major surgery. The safety of blood products has improved in terms of infectious complications over the last three decades due to advanced donor screening procedures and tests. Nevertheless, non-infectious complications including a blood-type mismatch, volume overload and immunologic and non-immunologic reactions to blood products can adversely affect clinical outcomes. It is thus important to implement a patient-specific strategy in diagnosing bleeding cause(s) and optimising haemostatic therapy. This strategy is an integral part of patient blood management applicable to many perioperative patients. Recent advances in the haemostatic management and transfusion include better understanding of the pathomechanisms of coagulopathy, availability of point-of-care coagulation monitoring and introductions of pathogen-inactivated plasma and factor concentrates as well as recombinant coagulation factors. Understanding the indications and limitations of conventional haemostatic therapy, and potential indications and complications relating to emerging haemostatic agents, is important for perioperative physicians. In this article, we discuss current issues related to allogeneic plasma products and emerging biological haemostatic agents and techniques. Further, we review the mechanisms of action and available preclinical or clinical data for each therapeutic agent., (Copyright © 2013 Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
9. Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest.
- Author
-
Sniecinski RM, Chen EP, Makadia SS, Kikura M, Bolliger D, and Tanaka KA
- Subjects
- Aged, Anticoagulants therapeutic use, Aorta surgery, Aorta, Thoracic surgery, Biomarkers, Blood Cell Count, Blood Transfusion economics, Cardiopulmonary Bypass, Cohort Studies, Female, Hemostasis, Humans, Male, Middle Aged, Predictive Value of Tests, Recombinant Proteins therapeutic use, Retrospective Studies, Antifibrinolytic Agents therapeutic use, Aprotinin therapeutic use, Blood Transfusion statistics & numerical data, Cardiac Surgical Procedures economics, Circulatory Arrest, Deep Hypothermia Induced economics, Factor VIIa therapeutic use, Tranexamic Acid therapeutic use
- Abstract
Objective: Aprotinin, once used to reduce allogeneic blood product transfusion during cardiac surgery, was withdrawn from the market in late 2007 over concerns of causing increased mortality. This study was undertaken to determine what, if any, the impact of changing antifibrinolytic agents (from aprotinin to tranexamic acid) for deep hypothermic circulatory arrest cases would have on blood bank resource utilization., Design: This a retrospective review., Setting: All cases were performed at a single university hospital., Participants: All patients underwent cardiac surgical procedures requiring deep hypothermic circulatory arrest performed by a single cardiac surgeon between January 2006 and November 2008., Intervention: All patients prior to November 15, 2007 received aprotinin as antifibrinolytic therapy, while those after that date received tranexamic acid for antifibrinolytic therapy., Measurements and Main Results: Blood transfusion data and recombinant factor VIIa use during the pre- and immediate postoperative period was collected for all patients during the study time period. There were no significant differences between the aprotinin (n = 82) and tranexamic acid (n = 78) groups with regard to baseline coagulation status or operative characteristics. Patients treated with tranexamic acid required more fresh frozen plasma (2.5 units, p < 0.001), platelets (0.5 units, p < 0.01), and cryoprecipitate (25 units, p < 0.001), and had a higher incidence of recombinant factor VIIa use (34.6% v 12.2%, p < 0.01) compared with patients in the aprotinin group., Conclusions: Patients treated with tranexamic acid required more clotting factors than the control group receiving aprotinin., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
10. Whole Blood Assay: Thromboelastometry – Bleeding Management Algorithms
- Author
-
Görlinger, Klaus, Iqbal, James, Dirkmann, Daniel, Tanaka, Kenichi A., and Teruya, Jun, editor
- Published
- 2021
- Full Text
- View/download PDF
11. Whole Blood Assay: Thromboelastometry
- Author
-
Görlinger, Klaus, Iqbal, Jameel, Dirkmann, Daniel, Tanaka, Kenichi A., and Teruya, Jun, editor
- Published
- 2016
- Full Text
- View/download PDF
12. Trends and predictions of perioperative transfusion and venous thromboembolism in hepatectomy using a North American Registry.
- Author
-
Ha, Monica, Stewart, Kenneth E., Butt, Amir L., Vandyck, Kofi B., Tran, Sydany, Jain, Ajay, Edil, Barish, and Tanaka, Kenichi A.
- Subjects
RED blood cell transfusion ,THROMBOEMBOLISM ,HEPATECTOMY ,ERYTHROCYTES ,BLOOD transfusion ,ODDS ratio - Abstract
Background: Studies indicate a link between allogeneic blood transfusion and venous thromboembolism (VTE) post‐major surgery. Analyzing trends and predictors of these outcomes after hepatectomy can inform risk management. Methods: The American College of Surgeons National Surgical Quality Improvement Program database was used for a retrospective analysis. Primary outcomes were perioperative red blood cell (RBC) transfusion and VTE events within 30 days of hepatectomy. Seven‐year trends and predictors were evaluated. Results: Among 29,131 hepatectomy patients, transfusion rates showed no statistically significant decreasing trends (p =.122) from 2014 to 2020 (18.13%–16.71%), while VTE rates showed a downward trend over the 7 years (p =.021); 17.2% received RBC transfusion, with higher rates in surgeries lasting ≥282 min (median: 220 min). Calculated RBC mass [hematocrit (%) × body weight (kg) × 10−5 × 70/√(body mass index/22)] at or below 1.5 L substantially increased transfusion odds. VTE was reported postoperatively in 2.6% of cases more frequently in longer cases involving transfusions. The adjusted odds ratio (aOR) of VTE escalated from the shortest operative time to the longest (3.17; 95% confidence interval [CI], 2.37–4.22). The adjusted odds of VTE doubled for transfused patients compared to non‐transfused patients (aOR, 2.19; 95% CI, 1.86–2.57). Conclusions: Rates of RBC transfusion and VTE rates hepatectomy have minimally changed in the recent years. VTE prevention is challenging in extended surgeries at increased risk of bleeding and RBC transfusions. Patient‐level data on coagulation and thromboprophylaxis can potentially refine risk assessment for postoperative VTE. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Impact of Preoperative Hematocrit, Body Mass Index, and Red Cell Mass on Allogeneic Blood Product Usage in Adult Cardiac Surgical Patients: Report From a Statewide Quality Initiative.
- Author
-
Tanaka, Kenichi A., Alejo, Diane, Ghoreishi, Mehrdad, Salenger, Rawn, Fonner, Clifford, Ad, Niv, Whitman, Glenn, Taylor, Bradley S., and Mazzeffi, Michael A.
- Abstract
The study aims were to evaluate current blood transfusion practice in cardiac surgical patients and to explore associations between preoperative anemia, body mass index (BMI), red blood cell (RBC) mass, and allogeneic transfusion. Multicenter retrospective study. Academic and non-academic centers. After Institutional Review Board approval, 26,499 patients who underwent coronary artery bypass grafting ± valve replacement/repair between 2011 and 2019 were included from the Maryland Cardiac Surgery Quality Initiative database. Patients were stratified into BMI categories (<25, 25 to <30, and ≥30 kg/m
2 ), and a multivariable logistic regression model was fit to determine if preoperative hematocrit, BMI, and RBC mass were associated independently with allogeneic transfusion. Preoperative anemia was found in 55.4%, and any transfusion was administered to 49.3% of the entire cohort. Females and older patients had lower BMI and RBC mass. Increased RBC and cryoprecipitate transfusions occurred more frequently after surgery in the lower BMI group. After adjustments, increased transfusion was associated with a BMI <25 relative to a BMI ≥30 at an odds ratio (OR) of 1.26 (95% confidence interval [CI]: 1.08-1.39). For each 1% increase in preoperative hematocrit, transfusion was decreased by 9% (OR: 0.91; 95% CI: 0.90-0.92). For every 500 mL increase in RBC mass, there was a 43% reduction of transfusion (OR: 0.57; 95% CI: 0.55-0.58). Transfusion probability modeling based on calculated RBC mass eliminated sex differences in transfusion risk based on preoperative hematocrit, and may better delineate which patients may benefit from more rigorous perioperative blood conservation strategy. [Display omitted] [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
14. Blood utilization in liver transplantation (BUILT): A multidisciplinary survey of transfusion practices.
- Author
-
DeSimone, Robert A., Hess, Aaron S., Rajendran, Pranesh, Tanaka, Kenichi A., Cushing, Melissa M., and Eichbaum, Quentin
- Subjects
LIVER transplantation ,BLOOD products ,BLOOD transfusion ,ERYTHROCYTES ,BLOOD transfusion reaction ,PHYSICIANS - Abstract
Background: The purpose of this study was to survey liver transplant centers in the United States to assess baseline practices in blood utilization and identify opportunities for standardization to optimize blood use in these complex cases. Study Design and Methods: Two surveys, one for transfusion medicine physicians and the other for anesthesiologists, were distributed to high‐volume liver transplant centers. Results: The response rate was 52% for both surveys. The majority of respondents (90%) indicated they issue a standardized number of blood products to start surgeries. The most common number of products issued before the start of cases were 10 red blood cells (RBC) and 10 plasma units with no platelets or cryoprecipitate. On average, fewer RBC (7.5) and plasma (7) units were transfused than issued. Decisions to transfuse RhD+ RBCs to RhD‐ patients and use antigen untested units in alloimmunized patients were mainly handled on a case‐by‐case basis. Many centers reported utilizing viscoelastic testing (97%) and cell salvage (97%). Most centers reported standardized, laboratory‐based intraoperative transfusion goals for RBCs (65%) and fibrinogen replacement (52%) but lacked a standardized approach for plasma (55%) and platelets (58%). Discussion: More blood products are issued during surgery than are transfused. Responses from anesthesiology providers suggest a broad consensus on practice. Almost all respondents use viscoelastic testing in the management of intraoperative coagulopathy, either alone or in combination with classical coagulation tests. The majority of programs do not transfuse clotting factor concentrates, including fibrinogen concentrate, prothrombin complex concentrates, and recombinant activated FVII, and do not use antifibrinolytics prophylactically. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. Patient blood management programmes: keeping the ball rolling.
- Author
-
Bolliger, Daniel, Tanaka, Kenichi A., and Steiner, Luzius A.
- Subjects
- *
BLOOD transfusion , *MEDICAL societies , *COST effectiveness - Abstract
Patient blood management programmes have been endorsed by the World Health Organization and multiple medical societies. It seems important to review the progress and results of patient blood management programmes so necessary modifications or new initiatives can be added to achieve their major goals. In this issue of the British Journal of Anaesthesia , Meybohm and colleagues show that a nationwide patient blood management programme had an impact and was potentially cost-effective in centres that previously utilised large amounts of allogeneic blood transfusions. Before implementing a programme, each institution might need to identify the area(s) of deficiency with respect to established patient blood management methods, which will warrant specific focus in subsequent clinical practice reviews. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. The FIBTEM paradox: Do coronary artery bypass grafting patients with high baseline FIBTEM clot firmness need more allogeneic blood transfusion?
- Author
-
Choi, Seung, Mazzeffi, Michael A., Henderson, Reney, Mondal, Samhati, Morita, Yoshihisa, Deshpande, Seema, and Tanaka, Kenichi A.
- Subjects
CORONARY artery bypass ,BLOOD transfusion ,SURGICAL complications ,RETROSPECTIVE studies ,THROMBELASTOGRAPHY ,BLOOD coagulation disorders ,FIBRINOGEN ,RESEARCH funding ,HEMATOPOIETIC stem cell transplantation ,HEMOSTATICS ,HEMORRHAGE - Abstract
Background: Fibrinogen thromboelastometry (FIBTEM) test is clinically used for rotational thromboelastometry as a surrogate measure of fibrinogen. Elevated fibrinogen might confer protection against bleeding after major surgery. This single-center study was conducted to assess any relationship between baseline FIBTEM value and exposure to allogeneic transfusion in patients undergoing coronary artery bypass grafting (CABG).Study Design and Methods: Data were obtained retrospectively from local FIBTEM data and the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database between 2016 and 2019. Preoperative FIBTEM 10-min amplitude (A10) was categorized as low (≤ 18 mm), intermediate (19-23 mm), or high (≥24 mm). The primary outcome was any transfusion during the hospitalization, including red blood cells (RBCs), platelets, plasma, and cryoprecipitate. A multivariable regression model was used to adjust for confounders and calculate an odds ratio (OR) for any transfusion.Results: The high FIBTEM group included more female and African-American patients, as well as urgent surgery. The STS predicted risks of morbidity and mortality were greater, and anemia was most prevalent with high FIBTEM. Unadjusted blood transfusion rates were increased with high FIBTEM due to RBC transfusion, but non-RBC transfusion was highest with low FIBTEM. After adjustments, a lower OR for transfusion was associated with high FIBTEM (0.426; 95% confidence interval, 0.199-0.914) compared to low FIBTEM.Conclusion: The high FIBTEM group frequently presented with anemia and comorbidities, and received more RBCs but not non-RBC products. Postoperative blood loss was less with high FIBTEM, and after adjustments, it conferred protection against any transfusion. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
17. Does standardization of fluid management reduce blood transfusion in scoliosis surgery?—Comments on Pardessus et al.
- Author
-
Sampson, Emma G., Butt, Amir L., Tanaka, Kenichi A., and Gomes, Marcos W.
- Subjects
BLOOD transfusion ,ADOLESCENT idiopathic scoliosis ,SCOLIOSIS ,STANDARDIZATION ,FLUIDS ,ORTHOPEDIC braces - Abstract
This article discusses a study on factors influencing blood transfusion in adolescent idiopathic scoliosis correction surgery. The authors raise concerns about certain aspects of the study's methodology and analysis. They highlight the need for standardized protocols for fluid management, including the use of esophageal doppler monitoring. The authors also question the exclusion of certain known risk factors from the statistical model and suggest that further research with a larger sample size is needed. Overall, caution should be exercised when applying the current findings in clinical practice. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
18. Red Blood Cell Transfusion and Postoperative Delirium in Hip Fracture Surgery Patients: A Retrospective Observational Cohort Study.
- Author
-
Raphael, Jacob, Hensley, Nadia B., Chow, Jonathan, Parr, K. Gage, McNeil, John S., Porter, Steven B., Taneja, Monica, Tanaka, Kenichi, and Mazzeffi, Michael
- Subjects
RED blood cell transfusion ,HIP fractures ,HIP surgery ,DELIRIUM ,BLOOD transfusion ,ERYTHROCYTES - Abstract
Background. Patients having hip fracture surgery are at high risk for postoperative delirium. Red blood cell (RBC) transfusion may increase postoperative delirium risk by causing neuroinflammation. We hypothesized that RBC transfusion would be associated with postoperative delirium in patients having hip fracture surgery. Methods. An observational cohort study was performed using the United States National Surgical Quality Improvement Program (NSQIP) participant use files for hip fracture from 2016 to 2018. Propensity score analysis and inverse probability of treatment weighting (IPTW) were used to reduce bias from confounding. An IPTW adjusted odds ratio for developing postoperative delirium was calculated for patients who received RBC transfusion during surgery or in the 72 hours after. Results. There were 20,838 patients who had eligible current procedural terminology (CPT) codes for primary hip fracture surgery and complete study data. After employing strict exclusions to balance covariates and reduce bias, 3,715 patients remained in the IPTW cohort. Of these, 626 patients (16.9%) received RBC transfusion and 665 patients (17.9%) developed postoperative delirium. IPTW adjustment led to good covariate balance between patients who received RBC transfusion and those who did not. Patients who received RBC transfusion had significantly higher odds of postoperative delirium, IPTW adjusted odds ratio = 1.21, 95% CI = 1.03 to 1.43, and P = 0.02. Discharge location also differed significantly between patients who received RBC transfusion and those who did not (P < 0.001) with in-hospital mortality or referral to hospice occurring in 1.6% of patients who received RBC transfusion and 1.3% of patients who were not transfused. Conclusion. RBC transfusion is associated with increased odds of postoperative delirium after hip fracture surgery and may be associated with worse clinical outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Beware of heterogeneity when assessing the bleeding risk using multi‐specialty and multi‐year database.
- Author
-
Hansen, Sandra, Butt, Amir L., Stewart, Kenneth E., and Tanaka, Kenichi A.
- Subjects
BLOOD platelet transfusion ,RED blood cell transfusion ,DATABASES ,HEMORRHAGE ,TOTAL knee replacement ,TOTAL hip replacement - Abstract
Restrictive transfusion strategies and antifibrinolytic therapy as part of patient blood management contributed to the recent transfusion practice changes.[5] Therefore, performing a subgroup analysis with year as a covariate would be insightful in future studies. Keywords: bleeding; blood transfusion; coagulation testing; surgery EN bleeding blood transfusion coagulation testing surgery 893 894 2 04/13/23 20230401 NES 230401 We read with great interest a recently published work by Lim and colleagues. on the association between preoperative coagulation tests and perioperative red blood cell (RBC) transfusion.[1] This retrospective analysis included 672,075 elective major surgical cases that occurred between 2004 and 2018 using the National Surgical Quality Improvement Program (NSQIP) database. For example, colectomy patients represented the majority of their general surgery codes, but transfusion rates substantially varied between laparoscopic and open colectomies for partial (4.1% vs. 9.4%) and total resection (15.2% vs. 29.6%) (Table 1). [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
20. Five-year trends in perioperative red blood cell transfusion from index cases in five surgical specialties: 2011 to 2015.
- Author
-
Mazzeffi, Michael A., See, John M., Williams, Brittney, Richards, Justin, Zimmerman, Darin, Galvagno, Samuel, Fontaine, Magali, and Tanaka, Kenichi
- Subjects
RED blood cell transfusion ,BLOOD transfusion ,ERYTHROCYTES ,MYOCARDIAL infarction ,KIDNEY failure ,KIDNEY diseases ,MYOCARDIAL infarction risk factors ,MEDICAL specialties & specialists ,ORTHOPEDIC surgery ,QUALITY assurance ,SURGERY practice ,AT-risk people ,RETROSPECTIVE studies ,EVALUATION of human services programs ,DESCRIPTIVE statistics ,PERIOPERATIVE care ,DISEASE risk factors - Abstract
Background: Red blood cell (RBC) transfusion can be life-saving; however, the risks of RBC transfusion have been increasingly recognized, and current guidelines recommend restrictive transfusion in most patients. We hypothesized that RBC transfusions are decreasing in surgical patients.Study Design and Methods: A retrospective review of the National Surgical Quality Improvement Program database was performed from 2011 to 2015. Index cases in five surgical specialties were studied: neurosurgery, thoracic surgery, gynecologic surgery, orthopedic surgery, and vascular surgery. Patient characteristics, preoperative laboratory values, and surgery details were compared between years. The study's primary outcome was perioperative RBC transfusion, which was compared over the 5-year period for each specialty. Secondary outcomes were myocardial infarction and renal failure after surgery. In addition, trends in RBC transfusion between low-risk and high-risk patients and between emergency and elective surgery were examined.Results: RBC transfusion decreased in all surgical specialties except for thoracic and gynecologic surgery. RBC transfusion decreased substantially in orthopedic surgery, falling from 22.4% in 2011 to 6.3% in 2015 (p ≤ 0.0001). High-risk patients had greater reductions in the receipt of RBC transfusion than low-risk patients, and there were no increases in myocardial infarction or renal failure after surgery in any specialty.Conclusion: RBC transfusion appears to be decreasing across multiple surgical specialties, with no apparent increase in myocardial infarctions or renal failure. This likely represents an important improvement in patient care. Continued efforts are needed to develop patient blood management programs and further reduce RBC transfusion. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
21. Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y12 inhibitors.
- Author
-
Mazzeffi, Michael A., Khang Lee, Taylor, Bradley, and Tanaka, Kenichi A.
- Subjects
PERIOPERATIVE care ,PLATELET aggregation inhibitors ,ASPIRIN ,THROMBOSIS ,CARDIOVASCULAR disease treatment ,BLOOD transfusion - Abstract
Platelets play pivotal roles in hemostasis as well as pathological arterial thrombosis. The combination of aspirin and a P2Y
12 inhibitor has become the mainstay therapy in the ageing population with cardiovascular conditions, particularly during and after percutaneous coronary intervention. A number of novel P2Y12 inhibitors has become available in the recent years, and they markedly vary in pharmacokinetic and pharmacodynamic properties. Perioperative physicians today face a challenge of preventing hemorrhage due to platelet inhibitors, while minimizing thrombotic risks. There are several point-of-care platelet function tests available in the peri-procedural assessment of residual platelet aggregation. However, these platelet function tests are not standardized in terms of sample processing, agonist type and potency as well as methods of detecting platelet activity. Understanding the differences in pharmacological properties of antiplatelet agents, principles of platelet function tests, and pertinent hemostatic strategies may be useful to anesthesiologists and intensivists who manage perioperative issues associated with antiplatelet agents. The objectives of this review are: 1) to discuss clinical data on aspirin and P2Y12 inhibitors relating to perioperative bleeding, 2) to outline different features of point-of-care platelet function tests, and 3) to discuss therapeutic options for the prevention and treatment of bleeding associated with antiplatelet agents. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
22. Point-of-Care Coagulation Testing in Cardiac Surgery.
- Author
-
Bolliger, Daniel and Tanaka, Kenichi A.
- Subjects
- *
POINT-of-care testing , *BLOOD coagulation , *CARDIAC surgery , *THROMBOPLASTIN , *BLOOD transfusion - Abstract
Bleeding complications after cardiac surgery are common and are associated with increased morbidity and mortality. Their etiology is multifactorial, and treatment decisions are time sensitive. Point-of-care (POC) testing has an advantage over standard laboratory tests for faster turn-around times, and timely decision on coagulation intervention(s). The most common POC coagulation testing is the activated clotting time (ACT), used to monitor heparin therapy while on cardiopulmonary bypass. Viscoelastic coagulation tests including thromboelastometry (ROTEM) and thromboelastography (TEG) have been recommended for the treatment of postoperative bleeding after cardiac surgery because the ROTEM/TEG-guided treatment algorithms reduced the use of blood products. Other POC tests are commercially available, but there is sparse evidence for their routine use in cardiac surgery. These devices include heparin management systems, POC prothrombin time and activated partial thromboplastin time, POC fibrinogen assay, and whole blood platelet function tests. There are multiple confounding elements and conditions associated with cardiac surgery, which can significantly alter test results. Anemia and thrombocytopenia are regularly associated with deviations in many POC devices. In summary, POC coagulation testing allows for rapid clinical decisions in hematological interventions, and, when used in conjunction with a proper transfusion algorithm, may reduce blood product usage, and potentially complications associated with blood transfusion. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
23. Impact of aspirin use on morbidity and mortality in massively transfused cardiac surgery patients: a propensity score matched cohort study.
- Author
-
Mazzeffi, Michael, Galvagno, Samuel, Gammie, James, and Tanaka, Kenichi
- Subjects
PHYSIOLOGICAL effects of aspirin ,CARDIAC surgery patients ,BLOOD transfusion ,LUNG injuries ,PREOPERATIVE care - Abstract
Purpose: Aspirin may prevent organ dysfunction in critically ill patients and mitigate transfusion associated acute lung injury. We hypothesized that aspirin use might be associated with decreased morbidity and mortality in massively transfused cardiac surgery patients. Methods: A single center retrospective cohort study was performed using data from an 8.5-year period (2006-2014). Massive transfusion was defined as receiving at least 2400 ml (8 units) of red blood cell units intraoperatively. A propensity score model was created to account for the likelihood of receiving aspirin and matched pairs were identified using global optimal matching. The primary endpoint, in-hospital mortality, was compared between aspirin users and non-users. Secondary outcomes including: ICU hours, mechanical lung ventilation hours, prolonged mechanical lung ventilation (>24 h), pneumonia, stroke, acute renal failure, atrial fibrillation, deep sternal wound infection, and multiple organ dysfunction syndrome were also compared. Results: Of 7492 cardiac surgery patients, 452 (6 %) were massively transfused and mortality was 30.6 %. There were 346 patients included in the matched cohort. No significant association was found between preoperative aspirin use and in-hospital mortality; absolute risk reduction with aspirin = 7.5 % (95 % CI −2.0 to 16.9 %, p = 0.12). Preoperative aspirin use was associated with fewer total mechanical lung ventilation hours ( p = 0.02) and less prolonged mechanical lung ventilation; absolute risk reduction = 11.0 % (95 % CI 1.1-20.5 %, p = 0.02). Conclusions: Preoperative aspirin use is not associated with decreased in-hospital mortality in massively transfused cardiac surgery patients, but may be associated with less mechanical lung ventilation time. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
24. Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.
- Author
-
Tanaka, Kenichi A., Egan, Katherine, Szlam, Fania, Ogawa, Satoru, Roback, John D., Sreeram, Gautam, Guyton, Robert A., and Chen, Edward P.
- Subjects
- *
BLOOD transfusion , *HEMATOLOGY , *BLOOD platelets , *FREEZE-drying , *FIBRINOGEN , *BLOOD plasma , *DATA analysis - Abstract
Background Platelet ( PLT) and plasma transfusion remain the mainstay hemostatic therapy for perioperative bleeding. Several studies have indicated that acquired fibrinogen ( FIB) deficiency can be the primary cause of bleeding after cardiac surgery. The aim of this study was to compare hematologic and transfusion profiles between the first-line FIB replacement and PLT transfusion in post-cardiac surgical bleeding. Study Design and Methods In this prospective, randomized, open-label study, 20 adult patients who underwent valve replacement or repair and fulfilled preset visual bleeding scale were randomized to 4 g of FIB or 1 unit of apheresis PLTs. Primary endpoints included hemostatic condition in the surgical field and 24-hour hemostatic product usage. Hematologic data, clinical outcome, and safety data were collected up to the 28th day postoperative visit. Results In patients who received the first-line FIB concentrate (n = 10), the visual bleeding scale improved after intervention, and the incidence of PLT transfusion and total plasma donor exposure were lower compared to the PLT group (n = 10). Postintervention FIB level was statistically higher (209 mg/ dL vs. 165 mg/ dL) in the FIB group than in the PLT group, but PLT count and prothrombin were lower. There were no statistical differences in the postoperative blood loss and red blood cell transfusion between two groups. Conclusions Our preliminary data indicate that the primary FIB replacement may potentially reduce the incidence of PLT transfusion and the number of donor exposures. Plasma FIB level of 200 mg/ dL is attainable with a single dose of 4 g, and this level seems to mitigate bleeding despite moderately decreased thrombin generation. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
25. Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: Comparison of fibrinogen concentrate with allogeneic blood products.
- Author
-
Solomon, Cristina, Schöchl, Herbert, Hanke, Alexander, Calatzis, Andreas, Hagl, Christian, Tanaka, Kenichi, and Rahe-Meyer, Niels
- Subjects
SURGICAL hemostasis ,CORONARY artery bypass ,BLOOD platelets ,COMPARATIVE studies ,FIBRINOGEN ,BLOOD products ,POSTOPERATIVE care - Abstract
Background. Patients undergoing coronary artery bypass grafting (CABG) are at risk of postoperative bleeding because of decreased platelet function and cardiopulmonary bypass (CPB)-induced haemostatic impairment. Fibrinogen concentration decreases by 34-42% of the preoperative level by the end of CPB. An inverse relationship between perioperative plasma fibrinogen levels and postoperative bleeding has been reported in CABG patients. Administration of fibrinogen concentrate after weaning from CPB in patients with diffuse microvascular bleeding may help promote haemostasis. We compared patient outcomes following fibrinogen concentrate administration or transfusion of allogeneics in CABG patients with decreased platelet function. Methods. Thirty-eight patients with decreased preoperative platelet function in Multiplate aggregometry were included. Patients with bleeding after CPB received either fibrinogen concentrate (guided by the measurement of fibrin clot quality using the FIBTEM thromboelastometric test) or allogeneics. Results. Twenty-nine of 38 patients received haemostatic therapy (bleeding ++ fibrinogen group, n == 10; bleeding ++ allogeneics group, n == 19). Total transfusion (median (interquartile range)) was significantly lower in the bleeding ++ fibrinogen group (0 (0, 3.8) units), compared with the bleeding ++ allogeneics group (6 (5, 8) units, p == 0.0073). Bolus administration of fibrinogen concentrate increased FIBTEM maximum clot firmness from 10.5 (9.3, 11) mm after CPB to 20.5 (20, 21.8) mm at the end of surgery. Postoperative outcomes were similar in both groups. No treatment-related complications were observed after fibrinogen concentrate. Conclusions. In CABG patients with bleeding after CPB, FIBTEM-guided administration of fibrinogen concentrate resulted in overall decreased transfusion, compared with haemostatic therapy with allogeneics. Fibrinogen concentrate administration increased the fibrin clot quality and helped achieve haemostasis. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
26. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery.
- Author
-
Rahe-Meyer, Niels, Solomon, Cristina, Winterhalter, Michael, Piepenbrock, Siegfried, Tanaka, Kenichi, Haverich, Axel, and Pichlmaier, Maximilian
- Subjects
FIBRINOGEN ,DRUG administration ,HEMORRHAGE treatment ,SURGICAL complications ,AORTIC aneurysms ,AORTA surgery ,THORACIC aneurysms ,ABDOMINAL aortic aneurysms ,BLOOD transfusion - Abstract
Objective: Thoracoabdominal aortic aneurysm operations are associated with extensive blood loss and high requirements for allogeneic blood product transfusion. We assessed the efficacy of intraoperative post–cardiopulmonary bypass administration of fibrinogen concentrate in elective thoracoabdominal aortic aneurysm surgery. Methods: In a retrospective group (group A, n = 12) of patients undergoing elective thoracoabdominal aortic aneurysm surgery, clinically relevant diffuse bleeding after weaning from cardiopulmonary bypass was treated with allogeneic blood products (platelet concentrates, followed by fresh frozen plasma) according to a predetermined algorithm. In a prospective group (group F, n = 6) a first therapy step with fibrinogen concentrate was added to the algorithm. The dose of fibrinogen concentrate was estimated by using thromboelastometric data (ROTEM FIBTEM). Before each step of hemostatic therapy, blood loss in the range of 60 to 250 g per 5 minutes was confirmed. Results: In group F, administration of 7.8 ± 2.7 g of fibrinogen concentrate established hemostasis, completely avoiding intraoperative transfusion of fresh frozen plasma and platelet concentrates. Transfusion of blood products after cardiopulmonary bypass and during the 24 hours after surgical intervention was markedly lower in group F than in group A (2.5 vs 16.4 units; 4/6 patients in group F required no transfusion of blood products), as was 24-hour drainage volume (449 vs 1092 mL). Fibrinogen plasma levels, standard coagulation parameters, and hemoglobin and hematocrit values were comparable between the 2 groups on the first postoperative day. Conclusions: FIBTEM-guided post–cardiopulmonary bypass administration of fibrinogen concentrate resulted in improved intraoperative management of coagulopathic bleeding in thoracoabdominal aortic aneurysm operations and reduced transfusion and 24-hour drainage volume. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
27. An Experience of Laser Surgery for Feto-Fetal Transfusion Syndrome Complicated with Unexpected Feto-Fetal Hemorrhage in a Case of Monochorionic Triamniotic Triplets.
- Author
-
Ishii, Keisuke, Murakoshi, Takeshi, Numata, Masahiro, Kikuchi, Akira, Takakuwa, Koichi, and Tanaka, Kenichi
- Subjects
FETAL diseases ,BLOOD transfusion ,TRIPLETS ,PROGNOSIS ,LIGHT coagulation ,BRADYCARDIA ,HEMORRHAGE - Abstract
Feto-fetal transfusion syndrome (FFTS) in monochorionic triplets is a rare clinical entity which may share the principal adverse perinatal outcomes of twin-twin transfusion syndrome. Recently, favorable prognoses regarding morbidity and mortality in twins after selective laser photocoagulation of placental communicating vessels (SLPCV) have been described. But descriptions of this procedure in monochorionic triplet cases are limited. This is the case report of an experience of SLPCV applied to monochorionic triamniotic triplets with FFTS. Triplet A had polyhydramnios, while absent end-diastolic flow in the umbilical artery of triplet B, the triplet with anhydramnios, was persistent. Triplet C looked normal, vertical amniotic pocket and Doppler studies yielding normal results. At the beginning of the SLPCV procedure, feto-fetal hemorrhage, subsequent to the fetal death of the donor triplet, occurred. Both surviving cofetuses showed persistent bradycardia; and 1 fetus died while the other recovered from the fetal bradycardia. All vascular anastomoses between the 3 triplets could be identified and obliterated, requiring two trocars. Our fetoscopic observation revealed feto-fetal hemorrhage after demise of monochorionic triplet, which led to injury of other fetuses due to hypovolemia in an instant. In conclusion, SLPCV might be a valid option for FFTS in triplet cases, while further experience is required in order to evaluate the risks and benefits of this procedure in triplet cases. Copyright © 2006 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
28. Temporal changes and predictors of perioperative blood transfusion in elective spine surgery: a retrospective analysis of a large surgical database.
- Author
-
Terada, Rui, Stewart, Kenneth, Hansen, Sandra, Shettar, Shashank S., Butt, Amir, Vallurupalli, Santaram, Martin, Michael, and Tanaka, Kenichi
- Subjects
- *
BLOOD transfusion , *ELECTIVE surgery , *SPINAL surgery , *DATABASES , *RECURSIVE partitioning , *ORTHOPEDIC surgery - Abstract
Allogeneic blood transfusion used to be common in spine surgery. Patient blood management has been widely adopted, and it is important to reassess transfusion predictors in contemporary practice. A retrospective study of inpatient spine surgery was performed using National Surgical Quality Improvement Program (NSQIP) data from 2011 to 2019. The primary outcome was perioperative transfusion within 72 h of surgery. Multivariable logistic regression and recursive partitioning were used to assess up to 15 variables including patient and surgical data, surgical specialty (orthopaedic surgery vs neurosurgery), and year of surgery. The study population included 251 971 US surgical patients; 6.9% of these patients received perioperative blood transfusion. Perioperative transfusions declined over time with the steepest decline from 2011 to 2015. The greatest reduction was seen among orthopaedic cases where the transfusion rate declined from 16.0% to 8.7% between 2011 and 2015. Eight variables were predictive factors in a reduced model: operative time, preoperative haemoglobin, vertebral level, number of vertebral levels, older age, surgeon specialty, arthrodesis, and year of surgery (area under the curve [AUC]=0.880; 95% confidence interval [CI], 0.878–0.883). Overall, longer operative time (>144 min) and greater numbers of vertebral levels had greater associations with transfusion than surgical specialty after adjustments. Prevalence of anaemia (15%) has not substantially declined. Perioperative blood transfusion rate in spine surgery has declined over the past decade. The extent and duration of surgery and preoperative haemoglobin level remain important factors associated with increased odds for perioperative blood transfusion. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. Thromboelastography Reaction-Time Thresholds for Optimal Prediction of Coagulation Factor Deficiency in Trauma.
- Author
-
Chow, Jonathan H., Fedeles, Benjamin, Richards, Justin E., Tanaka, Kenichi A., Morrison, Jonathan J., Rock, Peter, Scalea, Thomas M., Mazzeffi, Michael A., and TROPIC-Trauma Investigators
- Subjects
- *
BLOOD coagulation factors , *RECEIVER operating characteristic curves , *THROMBELASTOGRAPHY , *FORECASTING , *INTERNATIONAL normalized ratio , *INJURY complications , *WOUND care , *BLOOD transfusion , *BLOOD plasma , *PHARMACOKINETICS , *RETROSPECTIVE studies , *BLOOD coagulation disorders , *TRAUMA severity indices - Abstract
Background: Coagulopathy is common in multitrauma patients and repletion of procoagulant factor deficiency with fresh frozen plasma (FFP) improves hemostasis. Optimal kaolin-thromboelastography thresholds for FFP transfusion in trauma patients have not been well established.Study Design: Adult trauma patients with an Injury Severity Score ≥15 were included in this retrospective observational cohort study. The primary end point was area under the receiver operating characteristic curve (AUROC) for reaction time (R-time) to detect procoagulant factor deficiency, as reflected by an elevated international normalized ratio (INR) or aPTT. Test characteristics for the optimal R-time threshold calculated in our study were compared against thresholds recommended by the American College of Surgeons for FFP transfusion.Results: Six hundred and ninety-four pairs of thromboelastography and conventional coagulation tests were performed in 550 patients, with 144 patients having additional pairs of tests after the first hour. The R-time was able to detect procoagulant factor deficiency (INR ≥1.5 AUROC 0.80; 95% CI, 0.75 to 0.85; aPTT ≥40 seconds AUROC 0.85; 95% 0.80 to 0.89) and severe procoagulant factor deficiency (INR ≥2.0 AUROC 0.82; 95% CI, 0.73 to 0.99; aPTT ≥60 seconds AUROC 0.89; 95% CI, 0.81 to 0.98) with good accuracy. Optimal thresholds to maximize sensitivity and specificity were 3.9 minutes for detection of INR ≥1.5, 4.1 minutes for detection of aPTT ≥40 seconds, 4.3 minutes for detection of INR ≥2.0, and 4.3 for detection of aPTT ≥60 seconds. Currently recommended R-time thresholds for FFP transfusion had 100% specificity for detecting procoagulant factor deficiency, but low sensitivity (3% to 7%).Conclusions: R-time can detect procoagulant factor deficiency in multitrauma patients with good accuracy, but currently recommended R-time thresholds are highly specific and not sensitive. Use of low-sensitivity thresholds might result in undertreatment of many patients with procoagulant factor deficiency. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.